CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Suture- or Plug-Based Large-Bore Arteriotomy Closure: A Pilot Randomized Controlled Trial Modifiable lifestyle factors and heart failure: A Mendelian randomization study In-stent neoatherosclerosis: a final common pathway of late stent failure Heart Failure and Atrial Fibrillation, Like Fire and Fury Long-Term Outcomes of Anticoagulation for Bioprosthetic Valve Thrombosis Sequence variations in PCSK9, low LDL, and protection against coronary heart disease Incidence and Outcomes of Surgical Bailout During TAVR : Insights From the STS/ACC TVT Registry Dilated cardiomyopathy: so many cardiomyopathies! Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE

Clinical Trial2018 Oct 27. [Epub ahead of print]

JOURNAL:J Am Coll Cardiol. Article Link

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial

M Szarek, HD White, PH Steg, ODYSSEY OUTCOMES Committees and Investigators. Keywords: Alirocumab; acute coronary syndrome; total events

FuLL TEXT PDF